Bausch + Lomb previewed a forthcoming product and pointed to company-funded research showing treatment effects possible after two, four and eight weeks of daily use.
A single administration of a prostaglandin analog delivery device called iDose TR could help control pressure and reduce or eliminate the need for topical drops for well over a year.